I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

Shares of Equifax Inc. EFX slid 2.06% to $248.07 Thursday, on what proved to be an all-around mixed trading session for the ...

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high ...

Akero Therapeutics (AKRO) announced publication of 96-week final results from the Phase 2b HARMONY trial in The Lancet in adults with ...

We are not close. After my father passed, she kicked us to the curb - not only financially but also emotionally and as a parent. Even though I was 20 when he died, I grew up in a family where we were ...

Integrated Cyber Solutions (CSE: ICS), (OTCQB: IGCRF) (FRA: Y4G) ("ICS" or the "Company") is pleased to announce the appointment of Jeremy J. Samuelson as Technology Advisor to its Cyber ...

English actor and singer Michael Crawford, famed for originating The Phantom of the Opera role, has been named a 2025 Kennedy Center honoree ...